nach oben

Clinical Reviews in Allergy & Immunology

Erschienen in:

01.02.2010

Hematopoetic Stem Cell Transplantation in Neutrophil Disorders: Severe Congenital Neutropenia, Leukocyte Adhesion Deficiency and Chronic Granulomatous Disease

verfasst von: Ronit Elhasid, Jacob M. Rowe

Erschienen in: Clinical Reviews in Allergy & Immunology | Ausgabe 1/2010

Einloggen, um Zugang zu erhalten

Abstract

Until further progress will occur in the field of gene therapy, the only curative treatment available in severe congenital neutropenia, leukocyte adhesion deficiency, and chronic granulomatous disease is allogeneic hematopoietic stem cell transplantation (HSCT). This review summarizes the current data regarding indications for transplantation in each disease, treatment results using related and unrelated donors, as well as toxicity of HSCT in the above diseases.

Malech HL, Nauseef WM (1997) Primary inherited defects in neutrophil function: etiology and treatment. Semin Hematol 34:279–290PubMed

Kostmann R (1956) Infantile genetic agranulocytosis. Acta Paediatrica Scandinavica 45:1–78CrossRef

Kostmann R (1975) Infantile genetic agranulocytosis: a review with presentation of ten new cases. Acta Paediatrica Scandinavica 64:362–368CrossRef

Horwitz MS, Duan Z, Korkmaz B et al (2007) Neutrophil elastase in cyclic and severe congenital neutropenia. Blood 109:1817–1824CrossRefPubMed

Klein C, Grudzien M, Appaswamy G et al (2007) HAX1 deficiency causes autosomal recessive severe CN (Kostmann disease). Nat Genet 39:86–92CrossRefPubMed

Schaffer AA, Klein C (2007) Genetic heterogeneity in severe congenital neutropenia: how many aberrant pathways can kill a neutrophil? Curr Opin Allergy Clin Immunol 7:481–494CrossRefPubMed

Welte K, Zeidler C, Dale DC (2006) Severe congenital neutropenia. Semin Hematol 43:189–195CrossRefPubMed

Rosenberg PS, Alter BP Link DC (2007) Neutrophil elastase mutations and risk of leukemia in severe congenital neutropenia. Br J Haematol 140:210–213PubMed

Rosenberg PS, Alter BP, Bolyard AA et al (2006) Severe Chronic Neutropenia International Registry. The incidence of leukemia and mortality from sepsis in patients with severe CN receivivg long-term G-CSF therapy. Blood 107:4628–4635CrossRefPubMed

10.

Germeshausen M, Ballmaier M, Schulze H et al (2001) Granulocyte colony-stimulating factor receptor mutations in a patient with acute lymphoblastic leukemia secondary to severe CN. Blood 97:829–830CrossRefPubMed

11.

Germeshausen M, Schulze H, Kratz C et al (2005) An acquired G-CSF receptor mutation results in increased proliferation of CMML cells from a patient with severe CN. Leukemia 19:611–617PubMed

12.

Germeshausen M, Ballmaier M, Welte K (2007) Incidence of CSF3R mutations in severe CN and relevance for leukemogenesis: results of a long-term survey. Blood 109:93–99CrossRefPubMed

13.

Sloand EM, Yong AS, Ramkissoon S et al (2006) Granulocyte colony-stimulating factor preferentially stimulates proliferation of monosomy 7 cells bearing the isoform IV receptor. Proc Natl Acad Sci USA 103:14483–14488CrossRefPubMed

14.

Zeidler C, Germeshausen M, Klein C, Welre K (2009) Clinical implications of ELA2-, HAX1-, and G-CSF- receptor (CSF3R) mutations in severe congenital neutropenia. Br J of Haematol 144:459–467CrossRef

15.

Zeidler C, Welte K, Barak Y et al (2000) Stem cell transplantation in patients with severe CN without evidence of leukemic transformation. Blood 95:1195–1198PubMed

16.

Bellanne-Chantelot C, Clauin S, Leblanc T et al (2004) Mutations in the ELA2 gene correlate with more severe expression of neutropenia: a study of 81 patients from the French Neutropenia Register. Blood 103:4119–4125CrossRefPubMed

17.

Rappeport JM, Parkman R, Newburger P et al (1980) Correction of infantile agranulocytosis (Kostmann's syndrome) by allogeneic bone marrow transplantation. Am J Med 68:605–609CrossRefPubMed

18.

Dallorso S, Manzitti C, Dodero P et al (2003) Uneventful outcome of unrelated hematopoietic stem cell transplantation in a patient with leukemic transformation of Kostmann syndrome and long-lasting invasive pulmonary mycosis. Eur J Haematol 70:322–325CrossRefPubMed

19.

Toyoda H, Azuma E, Hori H et al (2001) Successful unrelated BMT in a patient with Kostmann syndrome complicated by pre-transplant pulmonary bacterial abscesses. Bone Marrow Transplant 28:413–415CrossRefPubMed

20.

Markel MK, Haut PR, Renbarger JA et al (2008) Unrelated cord blood transplantation for severe congenital neutropenia: report of two cases with very different transplant courses. Pediatr Transplant 12:896–901PubMedCrossRef

21.

Ferry C, Ouachee M, Leblanc T et al (2005) Hematopoietic stem cell transplantation in severe congenital neutropenia: experience of the French SCN register. Bone Marrow Transplant 35:45–50CrossRefPubMed

22.

Choi SW, Boxer LA, Pulsipher MA et al (2005) Stem cell transplantation in patients with severe congenital neutropenia with evidence of leukemic transformation. Bone Marrow Transplant 35:473–477CrossRefPubMed

23.

Touw IP, Bontenbal M (2007) Granulocyte colony-stimulating factor: key factor or innocent bystander in the development of secondary myeloid malignancy? JNCI 99:183–186PubMed

24.

Etzioni A, Harlan JM (2007) Cell adhesion and leukocyte adhesions defects. In: Smith EM, Puck J, Ochs HD eds. Primary Immune deficiency disease. A molecular and genetic approach, 2^nd ed. Oxford University Press 550-564.

25.

Hogg N, Stewart MP, Scarth SL, Newton R, Shaw JM, Law SK et al (1999) A novel leukocyte adhesion deficiency caused by expressed but nonfunctional beta2 integrins MAC-1 and LFA-1. J Clin Invest 103:97–106CrossRefPubMed

26.

Etzioni A, Frydman M, Pollack S, Avidor I, Phillips ML, Paulson JC et al (1992) Brief report: recurrent severe infections caused by a novel leukocyte adhesion deficiency. N Engl J Med 327:1789–1792PubMed

27.

Lubke T, Marquardt T, Etzioni A, Hatmann E, von Figura K, Korner C (2001) Complementation cloning identifies CDG-IIc, a new type of congenital disorders of glycosylation, as a GDP-fucose transporter deficiency. Nat Genet 28:73–76CrossRefPubMed

28.

Springer TA (1994) Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 76:301–314CrossRefPubMed

29.

Alon R, Etzioni A (2003) LAD III, a novel group of leukocyte integrin activation deficiencies. Trends Immunol 24:561–566CrossRefPubMed

30.

McDowall A, Inwald D, Leitinger B, Jones A, Liesner R, Klein N et al (2003) A novel form of integrin dysfunction involving beta 1, beta 2 and beta 3 integrins. J Clin Invest 111:51–60PubMed

31.

Mory A, Feigelson SW, Yarali N, Kilic SS, Bayhan GI, Gershoni-Baruch R, Etzioni A, Alon R (2008) Kindlin-3: a new gene involved in the pathogenesis of LAD-III. Blood 112:2591CrossRefPubMed

32.

Thomas C, Le Deist F, Cavazzana-Calvo M, Benkerrou M, Haddad E, Blanche S, Hartmann W, Friedrich W, Fischer A (1995) Results of allogeneic bone marrow transplantation in patients with leukocyte adhesion deficiency. Blood 86:1629–1635PubMed

33.

Fischer A, Pham HT, Descamps-Latscha B, Grospierre B, Gerota I, Perez N, Scheinmetzler C, Durandy A, Virelizier JL, Griscelli C (1983) Bone marrow transplantation for inborn error of phagocytic cells associated with defective adherence, chemotaxis and oxidative responses during opsonized particle phagocytosis. Lancet 2:473–476CrossRefPubMed

34.

Le Deist F, Blanche S, Keable H, Gaud C, Pham H, Descamps-Latscha B, Wahn V, Griscelli C, Fischer A (1989) Successful HLA non-identical bone marrow transplantation in three patients with the leukocyte adhesion deficiency. Blood 74:512–516PubMed

35.

Qasim W, Cavazzana-Calvo M, Davies EG, Davis J, Duval M, Eames G et al (2009) Allogeneic hematopoietic stem cell transplantation for leukocyte adhesion deficiency. Pediatrics 123:836–840CrossRefPubMed

36.

Mancias C, Infante AJ, Kamani NR (1999) Matched unrelated donor bone marrow transplantation in leukocyte adhesion deficiency. Bone Marrow Transplant 24:1261–1263CrossRefPubMed

37.

Farinha NJ, Duval M, Wagner E, Champagne J, Lapointe N, Barrette S, Tapiero B, Busque L, Champagne MA (2002) Unrelated bone marrow transplantation for leukocyte adhesion deficiency. Bone Marrow Transplant 30:979–981CrossRefPubMed

38.

Engel ME, Hickstein DD, Jr B, Calder C, Manes B, Frangoul H (2006) Matched unrelated bone marrow transplantation with reduced-intensity conditioning for leukocyte adhesion deficiency. Bone Marrow Transplant 37:717–718CrossRefPubMed

39.

Tokunaga M, Miyamura K, Ohashi H, Ishiwada N, Terakura S, Ikeguchi M et al (2007) Successful nonmyeloablative bone marrow transplantation for leukocyte adhesion deficiency type I from an unrelated donor. Int J Hematol 86:91–95CrossRefPubMed

40.

Kuijpers TW, van Bruggen R, Kamerbeek N, Tool ATJ, Hicsonmez G, Gurgey A, Karow A, Verhoeven AJ, Seeger K, Sanal O, Niemeyer C, Roos D (2007) Natural history and early diagnosis of LAD-1/variant syndrome. Blood 109:3529–3537CrossRefPubMed

41.

Kuijpers TW, van de Vijver E, Weterman MAJ, de Boer M, Tool ATJ, van den Berg TK, Moser M, Jakobs ME, Seeger K, Sanal O, Unal S, Cetin M, Roos D, Verhoeven AJ, Baas F (2009) LAD-1/variant syndrome is caused by mutations in FERMT3. Blood Dec 8 (in press)

42.

Winkelstein JA, Marino MC, Johnston RB Jr et al (2000) Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine (Baltimore) 79:155–169CrossRef

43.

Roos D, van Bruggen R, Meischl C (2003) Oxidative killing of microbes by neutrophils. Microbes and Infection 5:1307–1315CrossRefPubMed

44.

Clark RA, Klebanoff SJ (1979) Chemotactic factor inactivation by the myeloperoxidase-hydrogen peroxide-halide system. J Clin Invest 64:913–920CrossRefPubMed

45.

Seger RA (2008) Modern management of chronic granulomatous disease. British J of Haematology 140:255–266CrossRef

46.

Seger RA, Gungor T, Belohradsky BH, Blanche S, Bordigoni P, Di Bartolomeo P, Flood T et al (2002) Treatment of chronic granulomatous disease with myeloablative conditioning and an unmodified hemopoietic allograft: a survey of the European experience, 1985–2000. Blood 100:4344–4350CrossRefPubMed

47.

Schuetz C, Hoenig M, Gatz S, Speth F, Benninghoff U, Schulz A, Debatin KM, Friedrich W (2009) Hematopoietic stem cell transplantation from matched unrelated donors in chronic granulomatous disease. Immunol Res Oct 10 (in press).

48.

Horwitz ME, Barrett AJ, Brown MR, Carter CS, Childs R, Gallin JI, Holland SM, Linton GF, Miller JA et al (2001) Treatment of chronic granulomatous disease with nonmyeloablative conditioning and a T-cell depleted hematopoietic allograft. New England J of Medicine 344:881–888CrossRef

49.

Gungor T, Halter J, Klink A, Junge S, Stumpe KD, Seger R, Schanz U (2005) Successful low toxicity hematopoietic stem cell transplantation for high-risk adult chronic granulomatous disease patients. Transplantation 79:1596–1606CrossRefPubMed

50.

Dinauer MS, Gifford MA, Pech N, Li II, Emshwiller P (2001) Variable correction of host defense following gene transfer and bone marrow transplantation in murine X-linked chronic granulomatous disease. Blood 97:3738–3745CrossRefPubMed

51.

Stein S, Siler U, Ott MG, Seger R, Grez M (2006) Gene therapy for chronic granulomatous disease. Curr Opin Mol Ther 8:415–422PubMed

52.

Malech HL, Maples PB, Whiting-Theobald N, Linton GF, Sekhsaria S et al (1997) Prolong production of NADPH oxidase-corrected granulocytes after gene therapy of chronic granulomatous disease. Proceeding of the National Academy of Sciences of the United States of America 94:12133–12138CrossRef

53.

Malech HL, Choi U, Brenner S (2004) Progress toward effective gene therapy for chronic granulomatous disease. Jpn J Infect dis 57:S27–S28PubMed

54.

Ott MG, Schmidt M, Schwarzwaelder K, Strin S, Siler U, Koehl U, Glimm H, Kuhlcke K et al (2006) Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVII, PRDM16 or SETBP1. Nat Med 12:401–409CrossRefPubMed

55.

Ryser MF, Roesler J, Gentsch M, Brenner S (2007) Gene therapy for chronic granulomatous disease. Expert Opin Biol Ther 7:1799–1809CrossRefPubMed

Titel: Hematopoetic Stem Cell Transplantation in Neutrophil Disorders: Severe Congenital Neutropenia, Leukocyte Adhesion Deficiency and Chronic Granulomatous Disease
verfasst von: Ronit Elhasid
Jacob M. Rowe
Publikationsdatum: 01.02.2010
Verlag: Humana Press Inc
Erschienen in: Clinical Reviews in Allergy & Immunology / Ausgabe 1/2010
Print ISSN: 1080-0549
Elektronische ISSN: 1559-0267
DOI: https://doi.org/10.1007/s12016-009-8129-y

Neu im Fachgebiet HNO

16.04.2024 | HNO-Chirurgie | Nachrichten

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Hematopoetic Stem Cell Transplantation in Neutrophil Disorders: Severe Congenital Neutropenia, Leukocyte Adhesion Deficiency and Chronic Granulomatous Disease

Abstract

Neu im Fachgebiet HNO

HNO-Op. auch mit über 90?

Intrakapsuläre Tonsillektomie gewinnt an Boden

Bilateraler Hörsturz hat eine schlechte Prognose

RRP: Adjuvante HPV-Impfung in jedem Alter empfehlenswert

Update HNO

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2010

Contemporary Challenges in Human Innate Immunodeficiency Syndromes

The Role of Toll-Like Receptor Signaling in Human Immunodeficiencies

Genetic Insights into Congenital Neutropenia

Crohn’s Disease: an Immune Deficiency State

Chronic Granulomatous Disease

Use of Cytokine Therapy in Primary Immunodeficiency

Neu im Fachgebiet HNO

HNO-Op. auch mit über 90?

Intrakapsuläre Tonsillektomie gewinnt an Boden

Bilateraler Hörsturz hat eine schlechte Prognose

RRP: Adjuvante HPV-Impfung in jedem Alter empfehlenswert

Update HNO